Login / Signup
SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?
Paulus Stefan Rommer
Gabriel Bsteh
Thomas Berger
Uwe Klaus Zettl
Published in:
Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Keyphrases
</>
sars cov
multiple sclerosis
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors